NDC 49702-250

Rukobia

Fostemsavir Tromethamine

Rukobia is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Fostemsavir Tromethamine.

Product ID49702-250_3710c1a6-34c5-423d-8f79-3c98506ebcb6
NDC49702-250
Product TypeHuman Prescription Drug
Proprietary NameRukobia
Generic NameFostemsavir Tromethamine
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2020-07-02
Marketing CategoryNDA / NDA
Application NumberNDA212950
Labeler NameViiV Healthcare Company
Substance NameFOSTEMSAVIR TROMETHAMINE
Active Ingredient Strength600 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 49702-250-18

1 BOTTLE in 1 CARTON (49702-250-18) > 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Marketing Start Date2020-07-02
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Rukobia]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RUKOBIA
RUKOBIA
86825499 5117272 Live/Registered
Glaxo Group Limited
2015-11-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.